P

Inventor

HODGES JOHN C

US33 patents
⚠️ This page may combine multiple inventors who share the name “HODGES JOHN C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WARNER LAMBERT CO

28 patents
US5571792ANov 5, 1996

Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase

WARNER LAMBERT CO116 citations98
US5324483AJun 28, 1994

Apparatus for multiple simultaneous synthesis

WARNER LAMBERT CO400 citations98
US5246943ASep 21, 1993

Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties

WARNER LAMBERT CO139 citations98
US5036053AJul 30, 1991

Diol-containing renin inhibitors

WARNER LAMBERT CO130 citations97
US5063207ANov 5, 1991

Renin inhibitors, method for using them, and compositions containing them

WARNER LAMBERT CO107 citations96
US5612002AMar 18, 1997

Apparatus and method for multiple simultaneous synthesis

WARNER LAMBERT CO59 citations95
US4816463AMar 28, 1989

Substituted diimidazo [1,5-a: 4',5'-d]pyridines having antihypertensive activity

WARNER LAMBERT CO112 citations93
US4812462AMar 14, 1989

4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity

WARNER LAMBERT CO74 citations93
US5308853AMay 3, 1994

Substituted-5-methylidene hydantoins with AT1 receptor antagonist properties

WARNER LAMBERT CO43 citations92
US5338744AAug 16, 1994

Angiotensin II antagonists used to treat reproductive functions associated with AT2 receptors

WARNER LAMBERT CO40 citations90
US5525614AJun 11, 1996

Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin II receptor antagonist properties

WARNER LAMBERT CO18 citations81
US5350757ASep 27, 1994

Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin II receptor antagonist properties

WARNER LAMBERT CO12 citations81
US5210211AMay 11, 1993

4-(1h-pyrrol-1-yl) imidazoles with angiotension ii antagonist activity

WARNER LAMBERT CO16 citations74
US5045540ASep 3, 1991

Amino acid derivatives with angiotensin II antagonist properties

WARNER LAMBERT CO17 citations74
US5489686AFeb 6, 1996

Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin II receptor antagonist properties

WARNER LAMBERT CO5 citations73
US5260278ANov 9, 1993

Diol-containing renin inhibitors

WARNER LAMBERT CO6 citations73
US5198426AMar 30, 1993

Renin inhibitors containing c-terminal dihydroxy amides

WARNER LAMBERT CO7 citations73
US6506701B1Jan 14, 2003

Rapid purification by polymer supported quench

WARNER LAMBERT CO8 citations71
US6306959B1Oct 23, 2001

Rapid purification by polymer supported quench

WARNER LAMBERT CO13 citations71
US5444069AAug 22, 1995

Imidazo-pyridine angiotensin II antagonists used to treat memory loss

WARNER LAMBERT CO9 citations71
US5436260AJul 25, 1995

Angiotensin II receptor antagonists

WARNER LAMBERT CO4 citations63
US5276048AJan 4, 1994

4-(1H-pyrrol-1-yl)imidazoles with angiotensin II antagonist activity

WARNER LAMBERT CO5 citations63
US5041552AAug 20, 1991

Amino acid derivatives with angiotensin II antagonist properties

WARNER LAMBERT CO3 citations63
US4876343AOct 24, 1989

Process for statine and statine analogs

WARNER LAMBERT CO4 citations63
US5288851AFeb 22, 1994

Renin inhibitors, processes for preparing them, methods for using them, and compositions containing them

WARNER LAMBERT CO0 citations52
US5162527ANov 10, 1992

Renin inhibitors, processes for preparing them, methods for using them, and compositions containing them

WARNER LAMBERT CO1 citations52
US5061808AOct 29, 1991

2-oxo-1-pyrrolidine carboxylic acid esters

WARNER LAMBERT CO1 citations52
US6180718B1Jan 30, 2001

Process for preparation of aromatic and heteroaromatic molecules

WARNER LAMBERT CO1 citations51

HODGES JOHN C

3 patents

BASF AG

1 patent

BERRY AND ASSOCIATES INC

1 patent